Back to Companies
Crinetics Pharmaceuticals, Inc.
CRNXNasdaqCIK: 0001658247
Recent Form 4 activity at Crinetics Pharmaceuticals, Inc. (CRNX) spans 27 filings across 13 insiders (all of them on the sell side). Purchases total $0 against $7.5M in sales — heavily weighted toward selling, for net sales of $7.5M. Knight Jeff E. (Chief Dev. & Operating Officer) is the most active by dollar volume, and the single largest transaction was $6.9M by Knight Jeff E.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$20.9M
Purchases
$0
Sales
$7.5M
Unique Insiders
13
Recent Insider Trades
27 loaded
| Jul 7 | CRNX Crinetics Pharmaceuticals, Inc. | Vivaldi Coelho Rogerio | Director | Sell | $120.0K |
| Jun 22 | CRNX Crinetics Pharmaceuticals, Inc. | Bedrosian Camille L | Director | Grant | $349.0K |
| Jun 22 | CRNX Crinetics Pharmaceuticals, Inc. | Fust Matthew K | Director | Grant | $349.0K |
| Jun 22 | CRNX Crinetics Pharmaceuticals, Inc. | Deardorf Caren | Director | Grant | $349.0K |
| Jun 22 | CRNX Crinetics Pharmaceuticals, Inc. | Okey Stephanie | Director | Grant | $349.0K |
| Jun 22 | CRNX Crinetics Pharmaceuticals, Inc. | Vivaldi Coelho Rogerio | Director | Grant | $349.0K |
| Jun 22 | CRNX Crinetics Pharmaceuticals, Inc. | Nichols Weston | Director | Grant | $349.0K |
| Jun 22 | CRNX Crinetics Pharmaceuticals, Inc. | WIERENGA WENDELL | Director | Grant | $349.0K |
| Jun 18 | CRNX Crinetics Pharmaceuticals, Inc. | Okey Stephanie | Director | Sell | $246.1K |
| Jun 2 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Gift | $0 |
| Apr 10 | CRNX Crinetics Pharmaceuticals, Inc. | Knight Jeff E. | Chief Dev. & Operating Officer | Sell | $3.4M |
| Mar 18 | CRNX Crinetics Pharmaceuticals, Inc. | Knight Jeff E. | Chief Operating Officer | Sell | $370.4K |
| Mar 13 | CRNX Crinetics Pharmaceuticals, Inc. | Vivaldi Coelho Rogerio | Director | Sell | $180.8K |
| Mar 4 | CRNX Crinetics Pharmaceuticals, Inc. | Okey Stephanie | Director | Sell | $119.0K |
| Mar 4 | CRNX Crinetics Pharmaceuticals, Inc. | Schilke Tobin | Chief Financial Officer | Sell | $266.3K |
| Feb 25 | CRNX Crinetics Pharmaceuticals, Inc. | Betz Stephen F. | Chief Scientific Officer | Grant | $2.1M |
| Feb 25 | CRNX Crinetics Pharmaceuticals, Inc. | Knight Jeff E. | Chief Operating Officer | Grant | $2.4M |
| Jan 7 | CRNX Crinetics Pharmaceuticals, Inc. | Kalofonos Isabel | Chief Commercial Officer | Sell | $137.5K |
| Dec 29 | CRNX Crinetics Pharmaceuticals, Inc. | Betz Stephen F. | Chief Scientific Officer | Exercise | $68.8K |
| Dec 18 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Exercise | $1.2M |
| Dec 3 | CRNX Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Sell | $225.1K |
| Nov 5 | CRNX Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Sell | $213.3K |
| Oct 3 | CRNX Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Chief Med and Dev Officer | Sell | $209.1K |
| Sep 30 | CRNX Crinetics Pharmaceuticals, Inc. | Fust Matthew K | Director | Sell | $716.0K |
| Sep 30 | CRNX Crinetics Pharmaceuticals, Inc. | Struthers Richard Scott | President & CEO, Director | Sell | $180.0K |
| Aug 26 | CRNX Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Insider | Sell | $912.9K |
| Aug 21 | CRNX Crinetics Pharmaceuticals, Inc. | Pizzuti Dana | Insider | Sell | $189.4K |
27 filings